Literature DB >> 32592827

Antibiofilm and anti-caries effects of an experimental mouth rinse containing Matricaria chamomilla L. extract under microcosm biofilm on enamel.

Aline Silva Braga1, Leticia Lobo de Melo Simas1, Juliana Gonçalves Pires1, Beatriz Martines Souza1, Fernanda Pereira de Souza Rosa de Melo2, Luiz Leonardo Saldanha2, Anne Ligia Dokkedal2, Ana Carolina Magalhães3.   

Abstract

OBJECTIVE: This study evaluated the antibiofilm and anti-caries effects of an experimental mouth rinse containing aqueous extract of Matricaria chamomilla L.
METHODS: Microcosm biofilm was produced on bovine enamel, from pooled human saliva mixed with McBain saliva, under 0.2 % sucrose exposure, for 5 days. The biofilm was daily treated using (1 mL/1 min): Vochysia tucanorum Mart. (2.5 mg/mL); Myrcia bella Cambess. (1.25 mg/mL); Matricaria chamomilla L. (20 mg/mL); Malva sylvestris (Malvatricin® Plus-Daudt); 0.12 % Chlorhexidine (PerioGard®-Palmolive, Positive control) and PBS (Negative control). The % dead bacteria, biofilm thickness, EPS biovolume, lactic acid concentration, the CFU counting (total microorganisms, Lactobacillus sp., total streptococci and Streptococcus mutans/S. sobrinus) were determined. Enamel demineralization was measured by TMR.
RESULTS: All mouth rinses induced bacterial death compared to PBS (p < 0.0001). The biofilm thickness varied from 12 ± 2 μm (chlorhexidine) to 18 ± 2 μm (V. tucanorum) (ANOVA/Tukey, p < 0.0001). The EPS biovolume varied from 7(4)% (chlorhexidine) to 30(20)% (PBS) (Kruskal-Wallis/Dunn, p < 0.0001). The lactic acid production was reduced by M. sylvestris (1.1 ± 0.2 g/L) and chlorhexidine (0.6 ± 0.2 g/L) compared to PBS (2.6 ± 1.3 g/L) (ANOVA, p < 0.0001). Malva sylvestris and chlorhexidine showed significant low CFU for total microorganisms, Lactobacillus sp. and total streptococci. Only chlorhexidine significantly reduced S. mutans/S. sobrinus. CFUs for total streptococci and Lactobacillus sp, were also significantly reduced by M. chamomilla L. Malva sylvestris (63.4 % of mineral loss reduction), chlorhexidine (47.4 %) and M. chamomilla L. (39.4 %) significantly reduced enamel demineralization compared to PBS (ANOVA/Tukey, p < 0.0001).
CONCLUSION: M. chamomilla L. has lower antibiofilm action, but comparable anti-caries effect to those found for chlorhexidine, under this model. CLINICAL RELEVANCE: This study shows that the antibiofilm and anti-caries potential may vary between the commercial and experimental mouth rinses containing natural agents, with promising results for those containing Matricaria chamomilla L. and Malva Sylvestris.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dental caries; Enamel; Microcosm biofilm; Mouth wash; Natural agents

Year:  2020        PMID: 32592827     DOI: 10.1016/j.jdent.2020.103415

Source DB:  PubMed          Journal:  J Dent        ISSN: 0300-5712            Impact factor:   4.379


  3 in total

1.  Characterization of white spot lesions formed on human enamel under microcosm biofilm for different experimental periods.

Authors:  Flávia Mauad Levy; Aline Silva Braga; Vinícius Taioqui Pelá; Stacey Lavender; Dennis Zhang; Shira Pilch; Zilson Malheiros; Bernal Stewart; Ana Carolina Magalhães; Marília Afonso Rabelo Buzalaf
Journal:  J Appl Oral Sci       Date:  2022-04-01       Impact factor: 2.698

Review 2.  Chamomile (Matricaria chamomilla L.): A Review of Ethnomedicinal Use, Phytochemistry and Pharmacological Uses.

Authors:  Amina El Mihyaoui; Joaquim C G Esteves da Silva; Saoulajan Charfi; María Emilia Candela Castillo; Ahmed Lamarti; Marino B Arnao
Journal:  Life (Basel)       Date:  2022-03-25

3.  The Effect of Toothpastes Containing Natural Extracts on Bacterial Species of a Microcosm Biofilm and on Enamel Caries Development.

Authors:  Aline Silva Braga; Mohamed Mostafa Hefny Abdelbary; Rafaela Ricci Kim; Fernanda Pereira de Souza Rosa de Melo; Luiz Leonardo Saldanha; Anne Lígia Dokkedal; Georg Conrads; Marcella Esteves-Oliveira; Ana Carolina Magalhães
Journal:  Antibiotics (Basel)       Date:  2022-03-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.